Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma

Conclusions: These results suggest that DPHCC is associated with significantly lower overall survival than non-DPHCC, and that the poor prognosis among DPHCC patients may be related to the presence of CSCs expressing CD133 and EpCAM.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Jie Zhang, Ya-Peng Qi, Ning Ma, Fei Lu, Weng-Feng Gong, Bin Chen, Liang Ma, Jian-Hong Zhong, Bang-De Xiang, Le-Qun Li Tags: Research Paper Source Type: research